Ken Dror Shifra, Pavlotzky Elsa, Barak Mira
Clinical Microbiology Laboratory, Regional Laboratory Haifa and Western Galilee, Clalit Health Services, Nesher, Israel.
PLoS One. 2016 Jul 22;11(7):e0159440. doi: 10.1371/journal.pone.0159440. eCollection 2016.
Infectious gastroenteritis is a global health problem associated with high morbidity and mortality rates. Rapid and accurate diagnosis is crucial to allow appropriate and timely treatment. Current laboratory stool testing has a long turnaround time (TAT) and demands highly qualified personnel and multiple techniques. The need for high throughput and the number of possible enteric pathogens compels the implementation of a molecular approach which uses multiplex technology, without compromising performance requirements. In this work we evaluated the feasibility of the NanoCHIP® Gastrointestinal Panel (GIP) (Savyon Diagnostics, Ashdod, IL), a molecular microarray-based screening test, to be used in the routine workflow of our laboratory, a big outpatient microbiology laboratory. The NanoCHIP® GIP test provides simultaneous detection of nine major enteric bacteria and parasites: Campylobacter spp., Salmonella spp., Shigella spp., Giardia sp., Cryptosporidium spp., Entamoeba histolytica, Entamoeba dispar, Dientamoeba fragilis, and Blastocystis spp. The required high-throughput was obtained by the NanoCHIP® detection system together with the MagNA Pure 96 DNA purification system (Roche Diagnostics Ltd., Switzerland). This combined system has demonstrated a higher sensitivity and detection yield compared to the conventional methods in both, retrospective and prospective samples. The identification of multiple parasites and bacteria in a single test also enabled increased efficiency of detecting mixed infections, as well as reduced hands-on time and work load. In conclusion, the combination of these two automated systems is a proper response to the laboratory needs in terms of improving laboratory workflow, turn-around-time, minimizing human errors and can be efficiently integrated in the routine work of the laboratory.
感染性肠胃炎是一个全球性的健康问题,发病率和死亡率都很高。快速准确的诊断对于进行适当及时的治疗至关重要。目前的实验室粪便检测周转时间长,需要高素质的人员和多种技术。由于需要高通量检测以及可能的肠道病原体数量众多,因此必须采用分子方法,即使用多重技术,同时又不影响性能要求。在这项研究中,我们评估了NanoCHIP®胃肠道检测板(GIP)(以色列阿什杜德的Savyon Diagnostics公司)作为一种基于分子微阵列的筛查检测方法,在我们实验室(一家大型门诊微生物学实验室)的常规工作流程中使用的可行性。NanoCHIP® GIP检测可同时检测九种主要的肠道细菌和寄生虫:弯曲杆菌属、沙门氏菌属、志贺氏菌属、贾第虫属、隐孢子虫属、溶组织内阿米巴、迪斯帕内阿米巴、脆弱双核阿米巴和芽囊原虫属。NanoCHIP®检测系统与MagNA Pure 96 DNA纯化系统(瑞士罗氏诊断有限公司)相结合,实现了所需的高通量。在回顾性和前瞻性样本中,该组合系统均显示出比传统方法更高的灵敏度和检测率。在一次检测中同时鉴定多种寄生虫和细菌,还提高了检测混合感染的效率,减少了实际操作时间和工作量。总之,这两种自动化系统的组合是满足实验室需求的恰当方式,可改善实验室工作流程、缩短周转时间、减少人为误差,并能有效地融入实验室的日常工作。